AstraZeneca vaccine set to become first to get approval in India: Sources
Posted by
www.biotecnika.org
The decision would pave the way for the vaccine's rollout in the
world's second-most populous country which, after the United States,
has the highest number of COVID-19 infections in the world.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazeneca-vaccine-set-to-become-first-to-get-approval-in-india-sources/articleshow/80059777.cms
Subscribe to:
Post Comments (Atom)
March 18, 2025 at 9:36 PM
I’ve been researching fund options for a while, and Quant Mutual Fund keeps coming up as a strong performer. Many investors list it among the best quant mutual funds currently available. With the growing trust in quant funds in India, I’m seriously considering creating a quant mutual fund portfolio. Starting with a Best SIP seems like a smart and steady approach. Has anyone here tried a SIP in quant funds? Would appreciate any insights or tips!
April 8, 2025 at 6:16 AM
In a significant development in the fight against COVID-19, Geometry Dash Lite the AstraZeneca-Oxford vaccine is reportedly on track to become the first vaccine to receive emergency use authorization in India, according to government sources.
Post a Comment